Enhancement of bone healing using non-glycosylated rhBMP-2 released from a fibrin matrix in dogs and cats

H. G. Schmoekel; F. E. Weber; K. Hurter; J. C. Schense; G. Seiler; U. Rytz; D. Spreng; P. Schawalder; J. Hubbell

doi:10.1111/j.1748-5827.2005.tb00269.x

Enhancement of bone healing using non-glycosylated rhBMP-2 released from a fibrin matrix in dogs and cats

H. G. Schmoekel, F. E. Weber, K. Hurter, J. C. Schense, G. Seiler, U. Rytz, D. Spreng, P. Schawalder, J. Hubbell

Surgery

Research output: Contribution to journal › Article

17 Scopus citations

Abstract

OBJECTIVES: To test a non-glycosylated recombinant human bone morphogenetic protein-2 (ngly-rhBMP-2)/fibrin composite, which has been shown experimentally to enhance healing of bone defects in rodents, in a clinical case series of dogs and cats undergoing treatment for fracture non-unions and arthrodesis. METHODS: A ngly-rhBMP-2/fibrin composite was applied in 41 sites in 38 dogs and cats for which a cancellous bone autograft was indicated, replacing the graft. RESULTS: Bridging of the bone defect with functional bone healing was achieved in 90 per cent of the arthrodesis and fracture non-unions treated in this manner. CLINICAL SIGNIFICANCE: This prospective clinical study demonstrates the beneficial effects of ngly-rhBMP-2 in a specially designed fibrin matrix on the treatment of bone defects, and validates the use of this composite as an alternative to bone autografts in dogs and cats.

Original language	English (US)
Pages (from-to)	17-21
Number of pages	5
Journal	Journal of Small Animal Practice
Volume	46
Issue number	1
DOIs	https://doi.org/10.1111/j.1748-5827.2005.tb00269.x
State	Published - Jan 2005

Fingerprint

ASJC Scopus subject areas

Small Animals

Cite this

Schmoekel, H. G., Weber, F. E., Hurter, K., Schense, J. C., Seiler, G., Rytz, U., Spreng, D., Schawalder, P., & Hubbell, J. (2005). Enhancement of bone healing using non-glycosylated rhBMP-2 released from a fibrin matrix in dogs and cats. Journal of Small Animal Practice, 46(1), 17-21. https://doi.org/10.1111/j.1748-5827.2005.tb00269.x

@article{5efbf91fb4724cf6b53045573e201bf9,

title = "Enhancement of bone healing using non-glycosylated rhBMP-2 released from a fibrin matrix in dogs and cats",

abstract = "OBJECTIVES: To test a non-glycosylated recombinant human bone morphogenetic protein-2 (ngly-rhBMP-2)/fibrin composite, which has been shown experimentally to enhance healing of bone defects in rodents, in a clinical case series of dogs and cats undergoing treatment for fracture non-unions and arthrodesis. METHODS: A ngly-rhBMP-2/fibrin composite was applied in 41 sites in 38 dogs and cats for which a cancellous bone autograft was indicated, replacing the graft. RESULTS: Bridging of the bone defect with functional bone healing was achieved in 90 per cent of the arthrodesis and fracture non-unions treated in this manner. CLINICAL SIGNIFICANCE: This prospective clinical study demonstrates the beneficial effects of ngly-rhBMP-2 in a specially designed fibrin matrix on the treatment of bone defects, and validates the use of this composite as an alternative to bone autografts in dogs and cats.",

author = "Schmoekel, {H. G.} and Weber, {F. E.} and K. Hurter and Schense, {J. C.} and G. Seiler and U. Rytz and D. Spreng and P. Schawalder and J. Hubbell",

year = "2005",

month = jan

doi = "10.1111/j.1748-5827.2005.tb00269.x",

language = "English (US)",

volume = "46",

pages = "17--21",

journal = "Journal of Small Animal Practice",

issn = "0022-4510",

publisher = "Wiley-Blackwell",

number = "1",

}

TY - JOUR

T1 - Enhancement of bone healing using non-glycosylated rhBMP-2 released from a fibrin matrix in dogs and cats

AU - Schmoekel, H. G.

AU - Weber, F. E.

AU - Hurter, K.

AU - Schense, J. C.

AU - Seiler, G.

AU - Rytz, U.

AU - Spreng, D.

AU - Schawalder, P.

AU - Hubbell, J.

PY - 2005/1

Y1 - 2005/1

N2 - OBJECTIVES: To test a non-glycosylated recombinant human bone morphogenetic protein-2 (ngly-rhBMP-2)/fibrin composite, which has been shown experimentally to enhance healing of bone defects in rodents, in a clinical case series of dogs and cats undergoing treatment for fracture non-unions and arthrodesis. METHODS: A ngly-rhBMP-2/fibrin composite was applied in 41 sites in 38 dogs and cats for which a cancellous bone autograft was indicated, replacing the graft. RESULTS: Bridging of the bone defect with functional bone healing was achieved in 90 per cent of the arthrodesis and fracture non-unions treated in this manner. CLINICAL SIGNIFICANCE: This prospective clinical study demonstrates the beneficial effects of ngly-rhBMP-2 in a specially designed fibrin matrix on the treatment of bone defects, and validates the use of this composite as an alternative to bone autografts in dogs and cats.

AB - OBJECTIVES: To test a non-glycosylated recombinant human bone morphogenetic protein-2 (ngly-rhBMP-2)/fibrin composite, which has been shown experimentally to enhance healing of bone defects in rodents, in a clinical case series of dogs and cats undergoing treatment for fracture non-unions and arthrodesis. METHODS: A ngly-rhBMP-2/fibrin composite was applied in 41 sites in 38 dogs and cats for which a cancellous bone autograft was indicated, replacing the graft. RESULTS: Bridging of the bone defect with functional bone healing was achieved in 90 per cent of the arthrodesis and fracture non-unions treated in this manner. CLINICAL SIGNIFICANCE: This prospective clinical study demonstrates the beneficial effects of ngly-rhBMP-2 in a specially designed fibrin matrix on the treatment of bone defects, and validates the use of this composite as an alternative to bone autografts in dogs and cats.

UR - http://www.scopus.com/inward/record.url?scp=12444323529&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=12444323529&partnerID=8YFLogxK

U2 - 10.1111/j.1748-5827.2005.tb00269.x

DO - 10.1111/j.1748-5827.2005.tb00269.x

M3 - Article

C2 - 15682735

AN - SCOPUS:12444323529

VL - 46

SP - 17

EP - 21

JO - Journal of Small Animal Practice

JF - Journal of Small Animal Practice

SN - 0022-4510

IS - 1

ER -

Access to Document

10.1111/j.1748-5827.2005.tb00269.x